Tanabe, Subaru
Nakano, Yusuke
Ando, Hirohiko
Fujimoto, Masanobu
Onishi, Tomohiro
Ohashi, Hirofumi
Kuno, Shimpei
Naito, Kazuhiro
Waseda, Katsuhisa
Takahashi, Hiroshi
Suzuki, Yasushi
Fukuta, Motoyuki
Amano, Tetsuya
Article History
Received: 21 January 2024
Accepted: 29 March 2024
First Online: 3 April 2024
Competing interests
: Y.N. reported receiving lecture fees from Ono Pharma Co., Ltd., AstraZeneca, Otsuka Pharma Co., Ltd., Nihon Medi-Physics Co., Ltd., and Novartis Pharma Co., Ltd.; T.A. reported receiving lecture fees from Astellas Pharma Co., Ltd., AstraZeneca, Daiichi Sankyo, Otsuka Pharma Co., Ltd., Nihon Medi-Physics Co., Ltd., and Novartis Pharma Co., Ltd. Other authors do not have any conflicts of interest to declare.